Dashboard
Poor Management Efficiency with a low ROCE of 2.03%
- The company has been able to generate a Return on Capital Employed (avg) of 2.03% signifying low profitability per unit of total capital (equity and debt)
Poor long term growth as Net Sales has grown by an annual rate of -5.62% and Operating profit at -9.46% over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
Risky - Negative EBITDA
High Institutional Holdings at 43.82%
Market Beating Performance
Stock DNA
Specialty Chemicals
USD 88 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.45
-22.95%
0.42
Total Returns (Price + Dividend) 
Alto Ingredients, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Alto Ingredients, Inc. technically bullish or bearish?
As of 28 August 2025, the technical trend for Alto Ingredients, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The MACD shows a mildly bullish signal on both weekly and monthly time frames, while the Bollinger Bands indicate a bullish weekly stance but a mildly bearish monthly outlook. Moving averages on the daily chart are mildly bearish, and the KST and Dow Theory are both mildly bullish on the weekly and monthly charts. The RSI shows no signal in both time frames. In terms of performance, Alto Ingredients has outperformed the S&P 500 over the past week and month, with returns of 10.78% and 22.38%, respectively, compared to 1.05% and 2.33% for the benchmark. However, the year-to-date and one-year returns are significantly negative at -17.63% and -27.40%, respectively, while the S&P 500 has gained 12.22% and 17.14%....
Read MoreIs Alto Ingredients, Inc. overvalued or undervalued?
As of 14 March 2023, the valuation grade for Alto Ingredients, Inc. moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.37 and an EV to Sales ratio of 0.18, which suggest significant challenges in generating value relative to its assets and sales. Additionally, the EV to EBITDA ratio stands at -12.61, reflecting ongoing operational difficulties. In comparison to its peers, Alto Ingredients is underperforming; for instance, Westlake Chemical Partners LP has an EV to EBITDA of 2.5012, while Kronos Worldwide, Inc. boasts a much higher P/E ratio of 10.0112. These figures highlight the substantial gap in valuation and performance between Alto and its more successful competitors. Furthermore, the company's stock has significantly lagged behind the S&P 500, with a 1-year return of...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 18 Schemes (16.33%)
Held by 46 Foreign Institutions (7.3%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -3.58% vs -4.15% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 5.98% vs 71.94% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -21.06% vs -8.44% in Dec 2023
YoY Growth in year ended Dec 2024 is -110.71% vs 32.69% in Dec 2023






